Main Article Content

Abstract

Highlights:
1. This review comprehensively highlighted aspects of hematologic abnormalities in snakebites, a topic that remains understudied globally.
2. This review contributes insights into the field of snakebite research and improves the management of snakebites by examining the diverse effects of different types of snakebites on hemocoagulation status.


 


Abstract


Snakebite remains an underreported health hazard worldwide. The most common effects of snakebite envenomation globally are hematological disorders, with venom-induced consumption coagulopathy (VICC) being the most prevalent and significant condition. This review aimed to explore the hematological aspects of snakebite, with a focus on snakebite-induced consumption coagulopathy. We conducted a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines through a search across several databases, namely PubMed, ScienceDirect, and Google Scholar. The inclusion criteria for this review were studies on snakebite envenomation in humans with a discussion of relevant cases. Additionally, the included studies were conducted between 2010 and 2023 and published in the English language. Studies on animal models were excluded. We used the keywords “venom-induced consumption coagulopathy AND snake" in the search. The critical appraisal was performed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case Reports and the Mixed Methods Appraisal Tool (MMAT). The findings were presented as a qualitative synthesis of 14 articles covering 316 patients and various snakebite types. The studies on snakebite came from various countries, but mostly from Sri Lanka. The snake types exhibited variation, with certain species existing only in specific areas. The subjects fell into different age groups, from children to the elderly. The majority of the subjects were male. The subjects' youngest age was 6 years old, while the oldest was 70 years old. Prothrombin time (PT) and activated partial thromboplastin time (APTT) were the most discussed variables. Some of the studies demonstrated an increase in PT and APTT, although other studies reported contrasting findings. In conclusion, certain types of snakebite have a different impact on the hemocoagulation status.

Keywords

Hematology abnormalities snakebite mortality venom-induced consumption coagulopathy

Article Details

How to Cite
Rinta Prasetiyanti, & Yetti Hernaningsih. (2024). Hemocoagulation Conditions Associated with Venom-Induced Consumption Coagulopathy due to Snakebite in Humans. Folia Medica Indonesiana, 60(2), 156–166. https://doi.org/10.20473/fmi.v60i2.49436

References

  1. Alcoba G, Sharma SK, Bolon I, et al (2022). Snakebite epidemiology in humans and domestic animals across the Terai region in Nepal: A multicluster random survey. The Lancet Global Health 10, 398–408. doi: 10.1016/S2214-109X(22)00028-6.
  2. Berling I, Isbister GK (2015). Hematologic effects and complications of snake envenoming. Transfusion Medicine Reviews 29, 82–89. doi: 10.1016/j.tmrv.2014.09.005.
  3. Chien CY, Liao SC, Liao CH, et al (2017). Envenoming by Viridovipera stejnegeri snake: A patient with liver cirrhosis presenting disruption of hemostatic balance. Journal of Venomous Animals and Toxins including Tropical Diseases 23, 10. doi: 10.1186/s40409-017-0096-9.
  4. Dang XT, Xuan Nguyen T, Nguyen TTH, et al (2021). Coagulopathy after viper snakebite in Vietnam and relationship with time of admission. Journal of Multidisciplinary Healthcare 14, 1259–1265. doi: 10.2147/JMDH.S311556.
  5. Gopalakrishnan M, Yadav P, Mathur R, et al (2021). Venom-induced consumption coagulopathy unresponsive to antivenom after echis carinatus sochureki envenoming. Wilderness & Environmental Medicine 32, 221–225. doi: 10.1016/j.wem.2021.01.004.
  6. Greene S (2021). Snakebite. Medscape. Available at: https://emedicine.medscape.com/article/16882 8-overview?form=fpf#a4.
  7. Hong QN (2018). Mixed methods appraisal tool. McGill. Available at: http://mixedmethodsapprai saltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_EN G.pdf%0Ahttp://mixedmethodsappraisaltoolpublic.pbworks.com/.
  8. Ichiki T, Kohda F, Hiramatsu T, et al (2019). Early pathology in venom-induced consumption coagulopathy by Rhabdophis tigrinus (Yamakagashi snake) envenomation. Clinical Toxicology 57, 668–671. doi: 10.1080/15563650. 2018.1540045.
  9. Isbiter GK, Scorgie FE, O’Leary MA, et al (2010). Factor deficiencies in venom‐induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP‐10). Journal of Thrombosis and Haemostasis 8, 2504–2513. doi: 10.1111/j.1538-7836.2010.04050.x.
  10. Jeon YJ, Kim JW, Park S, et al (2019). Risk factor, monitoring, and treatment for snakebite induced coagulopathy: A multicenter retrospective study. Acute and Critical Care 34, 269–275. doi: 10.4266/acc.2019.00591.
  11. Johnston CI, Brown SGA, O’Leary MA, et al (2013). Mulga snake (Pseudechis australis) envenoming: A spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy – Australian Snakebite Project (ASP-19). Clinical Toxicology 51, 417–424. doi: 10.3109/15563650.2013.787 535.
  12. Keohane EM, Smith L, Walenga JM (2015). Rodak’s hematology: Clinical principles and applications. Elsevier. Available at: https://lab scientists.wordpress.com/wp-content/uploads/201 9/04/rodaks-hematology-5e-2016-unitedvrg-.pdf.
  13. Larréché S, Chippaux J-P, Chevillard L, et al (2021). Bleeding and thrombosis: Insights into pathophysiology of bothrops venom-related hemostasis disorders. International Journal of Molecular Sciences 22, 9643. doi: 10.3390/ijms 22179643.
  14. Maduwage K, Scorgie FE, Silva A, et al (2013). Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption. Clinical Toxicology 51, 527–531. doi: 10.3109/15563650. 2013.811589.
  15. McCleary RJR, Kini RM (2013). Snake bites and hemostasis/thrombosis. Thrombosis Research 132, 642–646. doi: 10.1016/j.thromres.2013.09. 031.
  16. de Medeiros CR, Duarte MR, de Souza SN (2021). Differential diagnosis between venomous ( Bothrops jararaca, Serpentes, Viperidae) and “Nonvenomous” (Philodryas olfersii, Serpentes, Dipsadidae) Snakebites: Is it always possible? Wilderness & Environmental Medicine 32, 522–527. doi: 10.1016/j.wem.2021.07.009.
  17. Microsoft Corporation, 2021. Microsoft Excel, Available at: https://office.microsoft.com/excel.
  18. Moon JM, Chun BJ, Cho YS, et al (2021). Coagulopathy after snake envenomation in South Korea. Clinical Toxicology 59, 905–912. doi: 10.1080/15563650.2021.1884694.
  19. Noutsos T, Currie BJ, Lek RA, et al (2020). Snakebite associated thrombotic microangiopathy: A systematic review of clinical features, outcomes, and evidence for interventions including plasmapheresis ed. Gutiérrez JM. PLOS Neglected Tropical Diseases 14, e0008936. doi: 10.1371/journal.pntd.0008936.
  20. Orak Y, Barcin T, Akbulut S, et al (2012). Disseminated intravascular coagulation and death due to snake bites. Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi/ Turkish Journal of Medical and Surgical Intensive Care 3, 17–18. doi: 10.5152/dcbybd.2012.05.
  21. Page MJ, McKenzie JE, Bossuyt PM, et al (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 71. doi: 10.1136/bmj.n71.
  22. Priyankara S, Rathnasiri V, Mihiran T, et al (2022). Mild venom-induced consumption coagulopathy associated with thrombotic microangiopathy following a juvenile Russell’s viper (Daboia russelii) envenoming: A case report. Toxicon 212, 8–10. doi: 10.1016/j.toxicon.2022.03.014.
  23. Puspaningtyas NW, Dewi R, Imanadhia A (2022). Snakebite: Current management. Journal Of The Indonesian Medical Association 72, 97–104. doi: 10.47830/jinma-vol.72.2-2022-386.
  24. Rathnayaka RMMKN, Ranathunga PEAN, Kularatne SAM (2020). Venom-induced consumption coagulopathy following nump-nosed pit viper (Genus: Hypnale ) envenoming in Sri Lanka: Uncertain efficacy of fresh frozen plasma. Wilderness & Environmental Medicine 31, 131–143. doi: 10.1016/j.wem.2019.12.006.
  25. Russell JJ, Schoenbrunner A, Janis JE (2021). Snake bite management: A scoping review of the literature. Plastic and Reconstructive Surgery - Global Open 9, e3506. doi: 10.1097/GOX.000000 0000003506.
  26. Seifert SA, I. Kirschner R, Martin N (2011). Recurrent, persistent, or late, new-onset hematologic abnormalities in Crotaline snakebite. Clinical Toxicology 49, 324–329. doi: 10.3109/15563650.2011.566883.
  27. Setiabudy RD (2009). Hemostasis dan trombosis. Balai Penerbit Fakultas Kedokteran Universitas Indonesia, Jakarta. Available at: https://lib.ui.ac.id/detail.jsp?id=20353106.
  28. Silva A, Scorgie FE, Lincz LF, et al (2022). Indian polyvalent antivenom accelerates recovery from venom-induced consumption coagulopathy (VICC) in Sri Lankan Russell’s viper (Daboia russelii) envenoming. Frontiers in Medicine. doi: 10.3389/fmed.2022.852651.
  29. Tawfik GM, Dila KAS, Mohamed MYF, et al (2019). A step by step guide for conducting a systematic review and meta-analysis with simulation data. Tropical Medicine and Health 47, 46. doi: 10.1186/s41182-019-0165-6.
  30. Valenta J, Hlavackova A, Stach Z, et al (2022). Fibrinogenolysis in venom-induced consumption coagulopathy after viperidae snakebites: A pilot study. Toxins (Basel) 14, 538. doi: 10.3390/toxins14080538.
  31. White J (2023). Snakebites worldwide: Clinical manifestations and diagnosis. UpToDate. Available at: https://medilib.ir/uptodate/show/ 6594.
  32. Wilson LM, Dong C, Chambers A, et al (2024). Prolonged venom-induced consumptive coagulopathy following Mangshan pit viper (Protobothrops mangshanensis) envenomation despite Hemato Polyvalent antivenom administration. Toxicon 238, 107563. doi: 10.1016/j.toxicon.2023.107563.
  33. World Health Organization (2016). Guidelines for the management of snakebites, 2nd edition. WHO. Available at: https://www.who.int/publications/ i/item/9789290225300.